Skip to content
healthcare.dev

Mounjaro

NDC 0002-1495, tirzepatide, injection, solution, from Eli Lilly and Company.

Product NDC
0002-1495
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215866
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1495 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIRZEPATIDE5 mg/.5mL

Pharmacologic classes

G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

Package NDCNDC-11Package
0002-1495-80000021495804 SYRINGE in 1 CARTON (0002-1495-80) / .5 mL in 1 SYRINGE (0002-1495-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  • NADAC price for package 00002149580

    GET /v1/drugs/nadac/00002149580

Use it

Look up 0002-1495 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1495 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-1495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.